Literature DB >> 22173228

Reciprocal metabolic perturbations in the adipose tissue and liver of GPIHBP1-deficient mice.

Michael M Weinstein1, Christopher N Goulbourne, Brandon S J Davies, Yiping Tu, Richard H Barnes, Steven M Watkins, Ryan Davis, Karen Reue, Peter Tontonoz, Anne P Beigneux, Loren G Fong, Stephen G Young.   

Abstract

OBJECTIVE: Gpihbp1-deficient (Gpihbp1-/-) mice lack the ability to transport lipoprotein lipase to the capillary lumen, resulting in mislocalization of lipoprotein lipase within tissues, defective lipolysis of triglyceride-rich lipoproteins, and chylomicronemia. We asked whether GPIHBP1 deficiency and mislocalization of catalytically active lipoprotein lipase would alter the composition of triglycerides in adipose tissue or perturb the expression of lipid biosynthetic genes. We also asked whether perturbations in adipose tissue composition and gene expression, if they occur, would be accompanied by reciprocal metabolic changes in the liver. METHODS AND
RESULTS: The chylomicronemia in Gpihbp1-/- mice was associated with reduced levels of essential fatty acids in adipose tissue triglycerides and increased expression of lipid biosynthetic genes. The liver exhibited the opposite changes: increased levels of essential fatty acids in triglycerides and reduced expression of lipid biosynthetic genes.
CONCLUSIONS: Defective lipolysis in Gpihbp1-/- mice causes reciprocal metabolic perturbations in adipose tissue and liver. In adipose tissue, the essential fatty acid content of triglycerides is reduced and lipid biosynthetic gene expression is increased, whereas the opposite changes occur in the liver.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22173228      PMCID: PMC3281771          DOI: 10.1161/ATVBAHA.111.241406

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  17 in total

1.  Adipose tissue fatty acid composition in humans with lipoprotein lipase deficiency.

Authors:  N F Ullrich; J Q Purnell; J D Brunzell
Journal:  J Investig Med       Date:  2001-05       Impact factor: 2.895

2.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

3.  Adipose fatty acid composition and rate of incorporation of alpha-linolenic acid differ between normal and lipoprotein lipase-deficient cats.

Authors:  Brian C Veltri; Robert C Backus; Quinton R Rogers; Edward J Depeters
Journal:  J Nutr       Date:  2006-12       Impact factor: 4.798

4.  Induced mutant mice expressing lipoprotein lipase exclusively in muscle have subnormal triglycerides yet reduced high density lipoprotein cholesterol levels in plasma.

Authors:  S Levak-Frank; P H Weinstock; T Hayek; R Verdery; W Hofmann; R Ramakrishnan; W Sattler; J L Breslow; R Zechner
Journal:  J Biol Chem       Date:  1997-07-04       Impact factor: 5.157

5.  Lipoprotein lipase controls fatty acid entry into adipose tissue, but fat mass is preserved by endogenous synthesis in mice deficient in adipose tissue lipoprotein lipase.

Authors:  P H Weinstock; S Levak-Frank; L C Hudgins; H Radner; J M Friedman; R Zechner; J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

6.  Endothelial lipase provides an alternative pathway for FFA uptake in lipoprotein lipase-deficient mouse adipose tissue.

Authors:  Dagmar Kratky; Robert Zimmermann; Elke M Wagner; Juliane G Strauss; Weijun Jin; Gerhard M Kostner; Guenter Haemmerle; Daniel J Rader; Rudolf Zechner
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

7.  Measurement of de novo hepatic lipogenesis in humans using stable isotopes.

Authors:  M K Hellerstein; M Christiansen; S Kaempfer; C Kletke; K Wu; J S Reid; K Mulligan; N S Hellerstein; C H Shackleton
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

8.  Defective uptake of triglyceride-associated fatty acids in adipose tissue causes the SREBP-1c-mediated induction of lipogenesis.

Authors:  Elke M Wagner; Dagmar Kratky; Guenter Haemmerle; Andelko Hrzenjak; Gert M Kostner; Ernst Steyrer; Rudolf Zechner
Journal:  J Lipid Res       Date:  2003-11-01       Impact factor: 5.922

9.  Adipose tissue triglyceride turnover, de novo lipogenesis, and cell proliferation in humans measured with 2H2O.

Authors:  A Strawford; F Antelo; M Christiansen; M K Hellerstein
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-11-04       Impact factor: 4.310

10.  Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650).

Authors:  Jian Wang; Robert A Hegele
Journal:  Lipids Health Dis       Date:  2007-09-20       Impact factor: 3.876

View more
  24 in total

1.  A new monoclonal antibody, 4-1a, that binds to the amino terminus of human lipoprotein lipase.

Authors:  André Bensadoun; Charlene D Mottler; Chris Pelletier; Daniel Wu; Jane J Seo; Calvin S Leung; Oludotun Adeyo; Chris N Goulbourne; Peter Gin; Loren G Fong; Stephen G Young; Anne P Beigneux
Journal:  Biochim Biophys Acta       Date:  2014-03-28

2.  Multimerization of glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) and familial chylomicronemia from a serine-to-cysteine substitution in GPIHBP1 Ly6 domain.

Authors:  Wanee Plengpanich; Stephen G Young; Weerapan Khovidhunkit; André Bensadoun; Hirankorn Karnman; Michael Ploug; Henrik Gårdsvoll; Calvin S Leung; Oludotun Adeyo; Mikael Larsson; Suwanna Muanpetch; Supannika Charoen; Loren G Fong; Sathit Niramitmahapanya; Anne P Beigneux
Journal:  J Biol Chem       Date:  2014-05-20       Impact factor: 5.157

3.  High-resolution imaging of dietary lipids in cells and tissues by NanoSIMS analysis.

Authors:  Haibo Jiang; Chris N Goulbourne; Angelica Tatar; Kirsten Turlo; Daniel Wu; Anne P Beigneux; Chris R M Grovenor; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2014-08-20       Impact factor: 5.922

Review 4.  Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 and the intravascular processing of triglyceride-rich lipoproteins.

Authors:  O Adeyo; C N Goulbourne; A Bensadoun; A P Beigneux; L G Fong; S G Young
Journal:  J Intern Med       Date:  2012-11-01       Impact factor: 8.989

Review 5.  Brown fat fuel utilization and thermogenesis.

Authors:  Kristy L Townsend; Yu-Hua Tseng
Journal:  Trends Endocrinol Metab       Date:  2014-01-02       Impact factor: 12.015

6.  Mutating a conserved cysteine in GPIHBP1 reduces amounts of GPIHBP1 in capillaries and abolishes LPL binding.

Authors:  Christopher M Allan; Cris J Jung; Mikael Larsson; Patrick J Heizer; Yiping Tu; Norma P Sandoval; Tiffany Ly P Dang; Rachel S Jung; Anne P Beigneux; Pieter J de Jong; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2017-05-05       Impact factor: 5.922

7.  GPIHBP1 missense mutations often cause multimerization of GPIHBP1 and thereby prevent lipoprotein lipase binding.

Authors:  Anne P Beigneux; Loren G Fong; André Bensadoun; Brandon S J Davies; Monika Oberer; Henrik Gårdsvoll; Michael Ploug; Stephen G Young
Journal:  Circ Res       Date:  2014-11-11       Impact factor: 17.367

Review 8.  Biochemistry and pathophysiology of intravascular and intracellular lipolysis.

Authors:  Stephen G Young; Rudolf Zechner
Journal:  Genes Dev       Date:  2013-03-01       Impact factor: 11.361

9.  Assessing mechanisms of GPIHBP1 and lipoprotein lipase movement across endothelial cells.

Authors:  Brandon S J Davies; Chris N Goulbourne; Richard H Barnes; Kirsten A Turlo; Peter Gin; Sue Vaughan; David J Vaux; André Bensadoun; Anne P Beigneux; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2012-09-24       Impact factor: 5.922

Review 10.  GPIHBP1 and Plasma Triglyceride Metabolism.

Authors:  Loren G Fong; Stephen G Young; Anne P Beigneux; André Bensadoun; Monika Oberer; Haibo Jiang; Michael Ploug
Journal:  Trends Endocrinol Metab       Date:  2016-05-14       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.